The years of obfuscation and delay prompted a Freedom of Information request by Business of Cannabis, which has established that the NHS will publish data from its ‘registry’ by the ‘end of the year’.
The Advisory Council for the Misuse of Drugs’ recent report on cannabis medicines is a missed opportunity, says Pierre Van Weperen of The Grow Group AS a leading distributor of unlicensed CBMPs in the UK, Grow Pharma welcomes research commissioned by the government into this very exciting and rapidly growing area.
NEW Government figures show a 900% increase in the number of cannabis medicines notified for import demonstrating the private sector’s growing role in fulfilling UK demand.
PATIENTS currently frozen out by an under-performing National Health Service are being offered access to cannabis medicine through a new private sector scheme.
UK MEDICAL cannabis distributor Grow Pharma has boosted its patient product range by 20% after striking a new deal with Althea Group Holdings.
